SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.8%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$1.42M
AUM Growth
+$1.42M
(+65%)
Cap. Flow
+$1.17M
Cap. Flow
% of AUM
82.19%
Top 10 Holdings %
Top 10 Hldgs %
85.81%
Holding
200
New
33
Increased
31
Reduced
36
Closed
37
Top Buys
| 1 |
Pfizer
PFE
|
$39.1K |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$27.4K |
| 3 |
Merck
MRK
|
$12K |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$11.6K |
| 5 |
Gilead Sciences
GILD
|
$10.7K |
Top Sells
| 1 |
Acadia Healthcare
ACHC
|
$16.4K |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$9.99K |
| 3 |
Tesla
TSLA
|
$7.93K |
| 4 |
Larimar Therapeutics
LRMR
|
$6.67K |
| 5 |
Ocular Therapeutix
OCUL
|
$4.66K |
Sector Composition
| 1 | Healthcare | 20.45% |
| 2 | Energy | 0.93% |
| 3 | Industrials | 0.31% |
| 4 | Consumer Staples | 0.23% |
| 5 | Technology | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cellectar Biosciences
CLRB
$15.3M
| $1.92K | 0.06% |
619,632
-110,977
| -15% | -$274 |
|
52
Xoma
XOMA
$421M
| $1.8K | 0.06% |
501,745
+67,427
| +16% | +$242 |
|
|
WGBS
53
DELISTED
WaferGen Bio-systems, Inc.
WGBS
| $1.76K | 0.06% |
585,255
+28,655
| +5% | +$86 |
|
54
Heron Therapeutics
HRTX
$204M
| $1.64K | 0.05% |
162,900
-22,100
| -12% | -$222 |
|
55
Sarepta Therapeutics
SRPT
$1.98B
| $1.52K | 0.05% |
105,000
-1,663
| -2% | -$24 |
|
|
BLRX
56
BioLineRX
BLRX
$15.5M
| $1.51K | 0.05% |
+928,758
| New | +$1.51K |
|
|
NPSP
57
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.49K | 0.05% |
41,670
+27,262
| +189% | +$975 |
|
|
CASC
58
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.38K | 0.04% |
724,500
-411,594
| -36% | -$782 |
|
|
SKBI
59
DELISTED
SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV)
SKBI
| $1.33K | 0.04% |
314,367
+25,257
| +9% | +$107 |
|
|
RVNC
60
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.29K | 0.04% |
76,400
-19,400
| -20% | -$329 |
|
|
OXGN
61
DELISTED
OXIGENE INC COM
OXGN
| $1.26K | 0.04% |
782,674
-404,924
| -34% | -$652 |
|
|
FOMX
62
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.15K | 0.04% |
163,300
-107,900
| -40% | -$757 |
|
63
CASI Pharmaceuticals
CASI
$36.1M
| $1.11K | 0.04% |
836,092
+47,607
| +6% | +$63 |
|
64
Achieve Life Sciences
ACHV
$146M
| $1.06K | 0.03% |
461,957
-325,131
| -41% | -$746 |
|
65
Imunon
IMNN
$14.4M
| $1.06K | 0.03% |
453,356
+343,921
| +314% | +$802 |
|
66
Plus Therapeutics
PSTV
$45.7M
| $1.03K | 0.03% |
2,096,392
-1,398,976
| -40% | -$647 |
|
|
CBAY
67
DELISTED
Cymabay Therapeutics
CBAY
| $991 | 0.03% |
100,800
-149,100
| -60% | -$1.47K |
|
|
MDGN.WS
68
DELISTED
MEDGENICS INC WT PUR COM EXP 03/31/16
MDGN.WS
| $922 | 0.03% |
1,271,240
+429,528
| +51% | +$311 |
|
|
NSPH
69
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $872 | 0.03% |
+2,225,081
| New | +$872 |
|
70
Alkermes
ALKS
$4.95B
| $810 | 0.03% |
13,827
-25,868
| -65% | -$1.52K |
|
|
TBRA
71
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $788 | 0.02% |
862,549
-149,001
| -15% | -$136 |
|
72
Incyte
INCY
$17B
| $772 | 0.02% |
+10,564
| New | +$772 |
|
73
Strata Skin Sciences
SSKN
$7.84M
| $719 | 0.02% |
599,262
+525,074
| +708% | +$630 |
|
|
NURO
74
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $708 | 0.02% |
362,874
+51,344
| +16% | +$100 |
|
75
Gevo
GEVO
$394M
| $601 | 0.02% |
1,878,020
-2,570,200
| -58% | -$822 |
|